Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of HealthEquity, Inc. (NASDAQ:HQY)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of HealthEquity, Inc. (NASDAQ:HQY). In a filing disclosed on July 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in HealthEquity stock on June 16th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 7/1/2025.
• Purchased $1,001 - $15,000 in shares of AppLovin NASDAQ: APP on 7/1/2025.
• Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 6/30/2025.
• Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 6/30/2025.
• Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 6/27/2025.
• Purchased $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 6/27/2025.
• Sold $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 6/27/2025.
• Sold $1,001 - $15,000 in shares of Willis Towers Watson Public NASDAQ: WTW on 6/26/2025.
• Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 6/26/2025.
• Sold $1,001 - $15,000 in shares of Liberty Media Corporation - Liberty Formula One Series C NASDAQ: FWONK on 6/26/2025.

HealthEquity Stock Performance

HQY stock traded up $0.61 during trading on Tuesday, hitting $97.69. The company had a trading volume of 196,006 shares, compared to its average volume of 868,304. The firm has a market cap of $8.45 billion, a PE ratio of 71.31, a price-to-earnings-growth ratio of 1.51 and a beta of 0.49. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The firm has a 50-day moving average price of $101.65 and a 200-day moving average price of $98.49. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter in the previous year, the firm posted $0.80 EPS. On average, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on HQY shares. JMP Securities increased their target price on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. Bank of America lifted their target price on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Barrington Research lifted their target price on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, June 5th. Royal Bank Of Canada lifted their target price on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. Finally, Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 price target (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, HealthEquity currently has an average rating of "Buy" and an average price target of $118.55.

Insider Transactions at HealthEquity

In related news, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares in the company, valued at $8,519,553.84. The trade was a 43.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the transaction, the executive vice president owned 53,225 shares in the company, valued at $5,414,579.25. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock worth $32,705,007 over the last quarter. Corporate insiders own 1.50% of the company's stock.

Institutional Trading of HealthEquity

Several hedge funds and other institutional investors have recently modified their holdings of HQY. Ameritas Investment Partners Inc. increased its position in HealthEquity by 0.3% in the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock valued at $3,248,000 after acquiring an additional 88 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in HealthEquity by 0.6% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock worth $1,850,000 after acquiring an additional 106 shares during the period. Ieq Capital LLC raised its position in HealthEquity by 4.4% in the first quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock worth $260,000 after acquiring an additional 123 shares during the period. Finally, Hancock Whitney Corp increased its stake in shares of HealthEquity by 1.0% in the fourth quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock worth $1,279,000 after purchasing an additional 133 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.